Literature DB >> 10350633

Localization of rabbit huntingtin using a new panel of monoclonal antibodies.

F L Wilkinson1, T M Nguyen, S B Manilal, P Thomas, J W Neal, P S Harper, A L Jones, G E Morris.   

Abstract

Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by the expansion of a CAG repeat which is expressed as a polyglutamine tract near the N-terminus of the gene product, huntingtin. N-terminal huntingtin fragments form intranuclear aggregates in HD patients and these may be involved in the pathogenesis. Monoclonal antibodies (mAbs) against three different regions of huntingtin (amino acids 997-1276, 1844-2131 and 2703-2911) have been produced and two of the epitopes have been identified using phage displayed peptide libraries. All mAbs reacted with 350 kDa huntingtin on Western blots and one mAb from each region was selected for further study by strong immunoreactivity with neurons in different regions of rabbit brain and by ability to immunoprecipitate native huntingtin. Subcellular fractionation and sucrose density centrifugation of rabbit brain extract showed that most of the huntingtin exists as a high molecular weight complex in the cytoplasm. Two outstanding problems have been addressed; the location of huntingtin in tissues outside the central nervous system and whether huntingtin is present in the nucleus of normal cells. We conclude that huntingtin is present at low levels in most non-neuronal cells though we have identified an interstitial cell type in skin with very high immunoreactivity. Using both immunolocalization and nuclear purification methods, we were unable to exclude the possibility that a small proportion of full-length huntingtin is present in the nucleus. Copyright 1999 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10350633     DOI: 10.1016/s0169-328x(99)00097-2

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  9 in total

Review 1.  Genetics and neuropathology of Huntington's disease.

Authors:  Anton Reiner; Ioannis Dragatsis; Paula Dietrich
Journal:  Int Rev Neurobiol       Date:  2011       Impact factor: 3.230

2.  Lentiviral-mediated delivery of mutant huntingtin in the striatum of rats induces a selective neuropathology modulated by polyglutamine repeat size, huntingtin expression levels, and protein length.

Authors:  Luis Pereira de Almeida; Christopher A Ross; Diana Zala; Patrick Aebischer; Nicole Déglon
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

3.  Body composition in premanifest Huntington's disease reveals lower bone density compared to controls.

Authors:  Anna O G Goodman; Roger A Barker
Journal:  PLoS Curr       Date:  2011-02-28

4.  Interaction of huntingtin with PRMTs and its subsequent arginine methylation affects HTT solubility, phase transition behavior and neuronal toxicity.

Authors:  Tamara Ratovitski; Mali Jiang; Robert N O'Meally; Priyanka Rauniyar; Ekaterine Chighladze; Anikó Faragó; Siddhi V Kamath; Jing Jin; Alexey V Shevelkin; Robert N Cole; Christopher A Ross
Journal:  Hum Mol Genet       Date:  2022-05-19       Impact factor: 5.121

5.  Muscleblind-like proteins: similarities and differences in normal and myotonic dystrophy muscle.

Authors:  Ian Holt; Virginie Jacquemin; Majid Fardaei; Caroline A Sewry; Gillian S Butler-Browne; Denis Furling; J David Brook; Glenn E Morris
Journal:  Am J Pathol       Date:  2008-12-18       Impact factor: 4.307

Review 6.  Wild-type huntingtin plays a role in brain development and neuronal survival.

Authors:  Anton Reiner; Ioannis Dragatsis; Scott Zeitlin; Daniel Goldowitz
Journal:  Mol Neurobiol       Date:  2003-12       Impact factor: 5.590

7.  Huntingtin localisation studies - a technical review.

Authors:  Alis Hughes; Lesley Jones
Journal:  PLoS Curr       Date:  2011-02-16

8.  The COOH-terminal domain of huntingtin interacts with RhoGEF kalirin and modulates cell survival.

Authors:  Hollis McClory; Xiaolong Wang; Ellen Sapp; Leah W Gatune; Maria Iuliano; Chiu-Yi Wu; Gina Nathwani; Kimberly B Kegel-Gleason; Marian DiFiglia; Xueyi Li
Journal:  Sci Rep       Date:  2018-05-22       Impact factor: 4.379

9.  Analysis of mutant and total huntingtin expression in Huntington's disease murine models.

Authors:  Valentina Fodale; Roberta Pintauro; Manuel Daldin; Roberta Altobelli; Maria Carolina Spiezia; Monica Bisbocci; Douglas Macdonald; Alberto Bresciani
Journal:  Sci Rep       Date:  2020-12-17       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.